Breast cancer remains the most common cancer and the leading cause of cancer-related death among women worldwide, with incidence rates continuing to rise. However, known risk factors, including genetics and lifestyle, do not fully explain the upward trend. Researchers are increasingly turning to metabolomics—the large-scale study of small molecules in biological systems—as a promising avenue for identifying new risk factors and improving prediction methods for breast cancer.

The principle of "food and medicine homology" (FMH), deeply embedded in traditional Chinese medicine, posits that certain natural substances can function as both food and medicine. A recent opinion piece posits that substances with FMH properties, recognized for their nutritional benefits and minimal toxicity, may present innovative opportunities in supplementary cancer treatment and prevention. The authors underscore the solid theoretical underpinnings and international acknowledgement of this approach, emphasizing how cutting-edge technologies can substantiate these age-old practices and facilitate their incorporation into modern, comprehensive cancer management programs.

Cervical cancer is the fourth most common cancer among women globally, according to the World Health Organization. It accounted for 660,000 new cases and 350,000 deaths in 2022.

Screening, along with early detection and treatment, can greatly improve a patient’s chances of survival. But in low- to middle-income countries, many women are not being screened, and they’re disproportionately dying from the disease.

In new research from Texas McCombs, Anima Nivsarkar, a doctoral student in marketing, uncovers a powerful tool to boost screening: trust. When messages are delivered by trusted and credible sources such as doctors and peers, they increase the likelihood that women will seek potentially life-saving exams.